Loading clinical trials...
Loading clinical trials...
Mechanisms that link metabolic syndrome to atherosclerosis are incompletely understood. As a part of Hämeenlinna Metabolic Syndrome Research Program (HMS) surrogate indicators for atherosclerosis are ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Kanta-Häme Central Hospital
Collaborators
NCT07669168 · Health Services Accessibility, Rural Health, and more
NCT07165678 · Coronary Heart Disease
NCT06277661 · Postpartum Depression, Postpartum Anxiety, and more
NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more
NCT07540949 · Obesity, Metabolic Syndrome
Linnan Klinikka
Hämeenlinna
Mehiläinen Hämeenlinna
Hämeenlinna
Central Hospital of Kanta-Häme
Hämeenlinna
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions